Bond.az White LogoBond.az Black Logo

Morgan Stanley hikes CAVA price target

Morgan Stanley raises CAVA price target to $86 on strong sales trends. Equalweight rating maintained despite valuation concerns.

Lucas Garcia
ByLucas Garcia- Senior Editor
|
0

Bond.az - Morgan Stanley raised its price target on CAVA Group Inc (NYSE:CAVA) to $86 from $85, maintaining an Equalweight rating.

First-quarter same-store sales rose 9.7%, beating estimates. Second-quarter trends remain strong. Revenue exceeded expectations by 4%, EBITDA by 8%.

Restaurant-level margins were 25.1%. Cost leverage was limited. New store performance, 6.8% traffic growth, salmon rollout, and unit growth are positive factors.

Morgan Stanley cited valuation concerns for the Equalweight rating. CAVA trades at a P/E of 147 and EV/EBITDA of 68.5. Shares are up 79% in six months.

More News
Today / 10:40
|
600

Citizens Upgrades Toll Brothers Rating on Strong Earnings

Citizens upgrades Toll Brothers rating after strong Q2 earnings beat, highlighting price and volume performance.

0
Today / 10:13
|
825

Stifel Raises Palo Alto Networks Target to $275

Stifel raises Palo Alto Networks price target to $275 amid strong demand and positive partner checks. Stock near 52-week high.

0
Today / 10:12
|
785

Raymond James Keeps Market Perform on CAVA

Raymond James maintains Market Perform rating on CAVA after impressive Q1 earnings with 9.7% comp sales growth and raised guidance.

0
Today / 10:02
|
685

Stifel raises Cava Group price target to $105

Stifel raises Cava Group price target to $105, citing strong comps and AI investments. Analysts remain bullish on growth.

0
Today / 10:01
|
779

Jefferies Raises Cava Target to $95 on Strong Sales

Jefferies raises Cava Group price target to $95 from $85, citing strong same-store sales growth and positive momentum. Maintains Buy rating.

0
Today / 09:01
|
899

Citizens Raises Rithm Capital Price Target

Citizens raises Rithm Capital price target to $13.50, highlighting asset growth and a shift to asset management. RITM offers a 11.11% dividend yield.

0
Today / 09:00
|
268

Citizens Raises Relay Price Target to $21

Citizens raises Relay Therapeutics price target to $21 on strong trial data for zovegalisib, with shares up 296%.

0
Today / 08:32
|
341

Raymond James Upgrades SM Energy on Oil Strength

Raymond James upgrades SM Energy to Outperform with $55 target on oil strength. SM Energy benefits from Iran war oil price surge.

0
Today / 08:21
|
408

Jefferies Initiates SAB Biotherapeutics with Buy

Jefferies initiates coverage on SAB Biotherapeutics with a Buy rating and $11 target, focusing on SAB-142 diabetes therapy.

0
Today / 08:03
|
826

UBS Upgrades Packaging Corp. Stock Rating

UBS upgraded Packaging Corp. of America from Neutral to Buy, raising price target to $248. Learn more about PKG stock on Bond.az.

0
Today / 08:02
|
746

BofA Maintains Buy on MakeMyTrip, $60 Target

BofA Securities reiterates Buy on MakeMyTrip (MMYT) with $60 target due to margin expansion and cost control in Q4 results.

0
Today / 07:55
|
540

RBC Capital Cuts Home Depot Target on Housing Woes

RBC Capital cuts Home Depot price target to $340 on housing concerns and higher interest rate outlook. Stock trades near 52-week low.

0
...
Morgan Stanley hikes CAVA price target | Bond.az